ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 186 filers reported holding ARCUS BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10,981 | -94.8% | 531 | -93.4% | 0.01% | -95.0% |
| Q3 2022 | $210,000 | +2.9% | 8,041 | 0.0% | 0.10% | +8.7% |
| Q2 2022 | $204,000 | -19.7% | 8,041 | 0.0% | 0.09% | -1.1% |
| Q1 2022 | $254,000 | -21.8% | 8,041 | 0.0% | 0.09% | -17.0% |
| Q4 2021 | $325,000 | +18.2% | 8,041 | 0.0% | 0.11% | +30.2% |
| Q3 2021 | $275,000 | +24.4% | 8,041 | 0.0% | 0.09% | +2.4% |
| Q2 2021 | $221,000 | -2.2% | 8,041 | 0.0% | 0.08% | -6.7% |
| Q1 2021 | $226,000 | +8.1% | 8,041 | 0.0% | 0.09% | +1.1% |
| Q4 2020 | $209,000 | +175.0% | 8,041 | 0.0% | 0.09% | +187.1% |
| Q4 2019 | $76,000 | – | 8,041 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |